Annual Cash & Cash Equivalents
$105.68M$288.90M-73.22%
Summary
- Current Value
- As of today, ACLX annual cash & cash equivalents is $105.68M, down -73.22% on
- Historical Performance
- ACLX annual cash & cash equivalents is up +242.75% over the past 3 years, and up +205.62% over the past 5 years
- All-Time High Comparison
- ACLX annual cash & cash equivalents is currently -73.22% below its historical high of $394.58M set on
- 3-Year Low Comparison
- ACLX annual cash & cash equivalents is +64.66% above its 3-year low of $64.18M reached on an earlier date
- Sector Comparison
- ACLX annual cash & cash equivalents is higher than 66.98% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $105.68M | -73.2% | +242.8% | +205.6% | +205.6% | |
| Quarterly Cash & Cash Equivalents | $461.38M | -19.7% | +64.3% | +890.2% | +890.2% | |
| Price | $68.45 | +4.7% | +107.4% | – | – | |
| Annual Current Assets | $599.31M | -16.3% | +431.3% | +1474.3% | +1474.3% | |
| Annual Total Liabilities | $256.54M | -24.5% | +1416.3% | +5172.0% | +5172.0% | |
| Annual Working Capital | $473.91M | -20.8% | +383.8% | +1252.8% | +1252.8% | |
| Annual Net Income | -$107.35M | -51.9% | -65.2% | -497.3% | -497.3% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $394.58M | -73.2% | |
| 5Y | $394.58M | -73.2% | |
| All | $394.58M | -73.2% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $64.18M | N/A | +64.7% |
| 5Y | $30.83M | +242.8% | |
| All | $30.83M | +242.8% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $105.68M | -73.2% | |
| $394.58M | +514.8% | |
| $64.18M | +108.2% |
| Year | Value | Change |
|---|---|---|
| $30.83M | -33.8% | |
| $46.60M | +34.8% | |
| $34.58M | - |
FAQ
What is the current annual cash & cash equivalents of ACLX?
As of today, ACLX annual cash & cash equivalents is $105.68M
What is 1-year change in ACLX annual cash & cash equivalents?
ACLX annual cash & cash equivalents is down -73.22% year-over-year
What is 3-year change in ACLX annual cash & cash equivalents?
ACLX annual cash & cash equivalents is up +242.75% over the past 3 years
How far is ACLX annual cash & cash equivalents from its all-time high?
ACLX annual cash & cash equivalents is currently -73.22% below its historical high of $394.58M set on December 31, 2023
How does ACLX annual cash & cash equivalents rank versus sector peers?
ACLX annual cash & cash equivalents is higher than 66.98% of companies in Healthcare sector
When is ACLX next annual earnings release?
The next annual earnings release for ACLX is on
Quarterly Cash & Cash Equivalents
$461.38M$8.28M+1.83%
Summary
- Current Value
- As of today, ACLX quarterly cash & cash equivalents is $461.38M, up +1.83% on
- Historical Performance
- ACLX quarterly cash & cash equivalents is down -19.68% year-over-year, and up +64.32% over the past 3 years
- All-Time High Comparison
- ACLX quarterly cash & cash equivalents is currently -34.46% below its historical high of $703.92M set on
- 3-Year Low Comparison
- ACLX quarterly cash & cash equivalents is +81.05% above its 3-year low of $254.84M reached on an earlier date
- Sector Comparison
- ACLX quarterly cash & cash equivalents is higher than 84.16% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $461.38M | +1.8% | -19.7% | +64.3% | +890.2% | |
| Annual Cash & Cash Equivalents | $105.68M | – | -73.2% | +242.8% | +205.6% | |
| Price | $68.45 | -18.6% | +4.7% | +107.4% | – | |
| Quarterly Current Assets | $472.08M | +1.8% | -19.6% | +62.6% | +856.5% | |
| Quarterly Total Liabilities | $215.14M | -5.2% | -23.7% | +112.9% | +2907.7% | |
| Quarterly Working Capital | $353.69M | +3.4% | -21.4% | +44.0% | +702.3% | |
| Quarterly Net Income | -$55.78M | -5.7% | -115.7% | +39.9% | -513.5% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $587.58M | N/A | -21.5% |
| 3Y | $703.92M | -34.5% | |
| 5Y | $703.92M | -34.5% | |
| All | $703.92M | -34.5% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $453.10M | +1.8% | |
| 3Y | $254.84M | N/A | +81.0% |
| 5Y | $46.60M | N/A | +890.2% |
| All | $46.60M | +890.2% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of ACLX?
As of today, ACLX quarterly cash & cash equivalents is $461.38M
What is ACLX quarterly cash & cash equivalents most recent change?
ACLX quarterly cash & cash equivalents was up +1.83% on September 30, 2025
What is 1-year change in ACLX quarterly cash & cash equivalents?
ACLX quarterly cash & cash equivalents is down -19.68% year-over-year
How far is ACLX quarterly cash & cash equivalents from its all-time high?
ACLX quarterly cash & cash equivalents is currently -34.46% below its historical high of $703.92M set on December 31, 2023
How does ACLX quarterly cash & cash equivalents rank versus sector peers?
ACLX quarterly cash & cash equivalents is higher than 84.16% of companies in Healthcare sector
When is ACLX next earnings release?
The next earnings release for ACLX is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- ACLX Official Website www.arcellx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1786205/000119312525266932/0001193125-25-266932-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1786205/000095017025029150/0000950170-25-029150-index.htm
- ACLX Profile on Yahoo Finance finance.yahoo.com/quote/ACLX
- ACLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aclx